DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,036 filers reported holding DANAHER CORPORATION in Q4 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $409,000 | +0.2% | 4,749 | -1.7% | 0.02% | -8.0% |
| Q2 2017 | $408,000 | -10.1% | 4,829 | -8.6% | 0.02% | -19.4% |
| Q1 2017 | $454,000 | +9.1% | 5,283 | -1.5% | 0.03% | 0.0% |
| Q4 2016 | $416,000 | +11.2% | 5,363 | +12.2% | 0.03% | +6.9% |
| Q3 2016 | $374,000 | -21.3% | 4,779 | +1.9% | 0.03% | -25.6% |
| Q2 2016 | $475,000 | +10.2% | 4,692 | +2.9% | 0.04% | -4.9% |
| Q1 2016 | $431,000 | +4.4% | 4,558 | +1.9% | 0.04% | -21.2% |
| Q4 2015 | $413,000 | +6.4% | 4,474 | -1.1% | 0.05% | +15.6% |
| Q3 2015 | $388,000 | +3.7% | 4,523 | +3.9% | 0.04% | +2.3% |
| Q2 2015 | $374,000 | +1.1% | 4,352 | 0.0% | 0.04% | -2.2% |
| Q1 2015 | $370,000 | +14.9% | 4,352 | +16.0% | 0.04% | +7.1% |
| Q4 2014 | $322,000 | +30.9% | 3,752 | +15.4% | 0.04% | +27.3% |
| Q3 2014 | $246,000 | +11.3% | 3,252 | +15.3% | 0.03% | +3.1% |
| Q2 2014 | $221,000 | – | 2,821 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |